SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 

DSM Q2 nutrition profits slip 11% as key markets struggle

By Shane Starling+

05-Aug-2014
Last updated on 05-Aug-2014 at 18:47 GMT2014-08-05T18:47:56Z

DSM Q2 nutrition profits slip 11% as key markets struggle

Sales slipped 6% and net profits 11% in Q2 for DSM’s human and animal nutrition arm as adverse currency movements, a slow US vitamins and omega-3 food supplements market and the Asian botulism infant formula scare affected earnings.

The company said recovery in the US supplements market, “was slower than expected” and that infant formula makers operating in China and south east Asia had reduced orders.

In a press call, Feike Sijbesma , CEO/chairman of the DSM Managing Board, said the Dutch ingredients giant was joining with US supplement partners to deliver education campaigns to combat negative press and highlight micronutrient deficiencies that affect 85% of Americans.

“In dietary supplements in the US already in the fourth quarter last year, due to some publications, a part of the market customers refrained a little bit but the majority of customers remained and continued to take those supplements and nutritional products,” Sijbesma said.

“But a certain part are not and that resulted in a decrease of the market.”

Education of a nation

Sijbesma said DSM along with, “some other industry players are initiating some campaigns to give the right education and the right information to the consumers about the importance of certain nutritional products and dietary supplements.”

 “We need to see in what time frame that could have an effect.”

Momentum in other markets was “positive” with the US-focused ‘i-Health’ (formerly Amerifit) consumer brand it gained with the acquisition of Martek BioSciences in 2011 in “robust” shape.

The CEO emphasised that while the Human Nutrition & Health division sales-profits were down year-on-year, the EBITDA profit contribution of €222m was actually up on the previous two quarters. Sales for quarter came in at €1.073bn compared to €1.111bn in Q2 2013.

Botulism backlash

In the press call, the company said the Chinese focused botulism-infant formula scare  provoked a false alarm around a, “New Zealand supplier”.

Recent changes in Chinese regulatory policy have created additional uncertainty for the industry. As a result infant nutrition suppliers have reduced their inventories.”

But the company remained committed to the Chinese market with recent investments in Vitamin C and B6 cited in the press call as examples.

While retaining a healthy 20.7% EBITDA-earnings margin, chief financial officer (CFO) Rolf Dieter-Schwalb said the overall outlook for the firm had been lowered “a little bit”.

Of the political instability and economic sanctions being imposed on Russia, Sijbesma noted it was, “a small market with DSM so impact is limited.”

Its broader food and beverage markets continued to show, “sluggish growth, while demand for premixes stayed healthy.”

“In order to stimulate growth, ‘A-label’ customers are investing in new product launches, promotional campaigns and acceleration of innovations,” DSM said.

More details about DSM’s Q2 results can be found here .

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars